Some patients report improved mood and reduced food-related anxiety, while others experience initial jitteriness or emotional blunting during dose escalation
GLP-1RAs represent a promising new strategy for patients with psychiatric disorders, offering the possibility of meaningful weight loss while also improving metabolic health changes that can significantly enhance quality of life. They undertook a systematic review and meta-analysis of ultimately nine RCTs to assess the efficacy and safety of GLP-1 RAs in individuals with psychiatric disorders (specifically, schizophrenia or schizoaffective disorder, bipolar disorder, psychosis, major depressive disorder, binge-eating disorder, or a combination) and obesity/overweight, focusing on weight and metabolic outcomes
Notably, evidence suggests that six months therapy with a fixed combination of Liraglutide and Degludec in a group of very old DM2 subjects who responded to treatment showed changes in n Gram-negative Alistipes gut microbiota , correlating with cognitive improvement 60
The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer
The interaction between CD4 T cells and APCs dictates T cell differentiation into Th1, Th2, Treg, or Th17 subsets